Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


15.04.2019

2 AJR Am J Roentgenol
4 Anticancer Res
1 BMC Cancer
4 Dig Dis Sci
2 Gut
7 Hepatology
1 Indian J Gastroenterol
2 Int J Cancer
1 J Gastroenterol Hepatol
4 J Hepatol
1 J Pediatr
6 Lancet Gastroenterol Hepatol
1 Lancet Haematol
5 Lancet Oncol
1 N Engl J Med
8 PLoS One
1 Semin Liver Dis


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. SMITH AD, Porter KK, Elkassem AA, Sanyal R, et al
    Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis.
    AJR Am J Roentgenol. 2019 Apr 11:1-13. doi: 10.2214/AJR.19.21144.
    PubMed     Text format     Abstract available

  2. WALSER EM
    Lollipops.
    AJR Am J Roentgenol. 2018;210:W182.
    PubMed     Text format    


    Anticancer Res

  3. YAMADA M, Yamamoto Y, Sugiura T, Kakuda Y, et al
    Comparison of the Clinicopathological Features in Small Bile Duct and Bile Ductular Type Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2019;39:2121-2127.
    PubMed     Text format     Abstract available

  4. MIYATA T, Beppu T, Imamura YU, Hayashi H, et al
    A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.
    Anticancer Res. 2019;39:2139-2144.
    PubMed     Text format     Abstract available

  5. NAGAI H, Mukozu T, Kobayashi K, Amanuma M, et al
    Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by Etiology.
    Anticancer Res. 2019;39:2183-2191.
    PubMed     Text format     Abstract available

  6. KIM SS, Eun JW, Cho HJ, Lee HY, et al
    Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma.
    Anticancer Res. 2019;39:2217-2226.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. BUISMAN FE, Homs MYV, Grunhagen DJ, Filipe WF, et al
    Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    BMC Cancer. 2019;19:327.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  8. JOPSON L, Khanna A, Peterson P, Rudell E, et al
    Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5074.
    PubMed     Text format     Abstract available

  9. LENHART A, Hussain S, Salgia R
    Chances of Renal Recovery or Liver Transplantation After Hospitalization for Alcoholic Liver Disease Requiring Dialysis.
    Dig Dis Sci. 2018 Jun 22. pii: 10.1007/s10620-018-5170.
    PubMed     Text format     Abstract available

  10. SHETTY A, Hsu JW, Manka PP, Syn WK, et al
    Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018;63:3187-3206.
    PubMed     Text format     Abstract available

  11. CHASCSA DM, Lai JC, Dunn MA, Montano-Loza AJ, et al
    Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5271.
    PubMed     Text format     Abstract available


    Gut

  12. SCOAZEC JY
    Hepatocellular adenomas: one step beyond.
    Gut. 2019 Apr 9. pii: gutjnl-2019-318299. doi: 10.1136/gutjnl-2019-318299.
    PubMed     Text format    

  13. CHE L, Chi W, Qiao Y, Zhang J, et al
    Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
    Gut. 2019 Apr 6. pii: gutjnl-2018-317581. doi: 10.1136/gutjnl-2018-317581.
    PubMed     Text format     Abstract available


    Hepatology

  14. LI N, Wei L, Liu X, Bai H, et al
    A frizzled-like cysteine rich domain in glypican-3 mediates Wnt binding and regulates hepatocellular carcinoma tumor growth in mice.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30646.
    PubMed     Text format     Abstract available

  15. CHIU V, Hogen R, Sher L, Wade N, et al
    Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30557.
    PubMed     Text format     Abstract available

  16. HE Y, Hwang S, Cai Y, Kim SJ, et al
    MicroRNA-223 ameliorates nonalcoholic steatohepatitis and cancer by targeting multiple inflammatory and oncogenic genes in hepatocytes.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30645.
    PubMed     Text format     Abstract available

  17. TRIVEDI HD, Lau DTY, Kulai TB, Malhi H, et al
    Hepatology Highlights.
    Hepatology. 2019;69:1849-1851.
    PubMed     Text format    

  18. CHEN YJ, Tsai CF, Wang YP, Lu CL, et al
    To the editor: Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics.
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30641.
    PubMed     Text format     Abstract available

  19. DHANASEKARAN R, Felsher DW
    A Tale of Two Complications of Obesity: Nonalcoholic steatohepatitis (NASH) and Hepatocellular carcinoma (HCC).
    Hepatology. 2019 Apr 8. doi: 10.1002/hep.30649.
    PubMed     Text format     Abstract available

  20. DESROCHES-CASTAN A, Tillet E, Ricard N, Ouarne M, et al
    BMP9 is a paracrine factor controlling liver sinusoidal endothelial cell fenestration and protecting from hepatic fibrosis.
    Hepatology. 2019 Apr 9. doi: 10.1002/hep.30655.
    PubMed     Text format     Abstract available


    Indian J Gastroenterol

  21. SHAH D, Makharia GK, Ghoshal UC, Varma S, et al
    Burden of gastrointestinal and liver diseases in India, 1990-2016.
    Indian J Gastroenterol. 2018;37:439-445.
    PubMed     Text format     Abstract available


    Int J Cancer

  22. YANG P, Huang X, Lai C, Li L, et al
    SET domain containing 1B gene (SETD1B) is mutated in primary hepatic neuroendocrine tumors.
    Int J Cancer. 2019 Apr 11. doi: 10.1002/ijc.32334.
    PubMed     Text format     Abstract available

  23. GE Z, Feng Y, Sheh A, Muthupalani S, et al
    Mutagenicity of Helicobacter hepaticus infection in the lower bowel mucosa of 129/SvEv Rag2(-/-) Il10(-/-) gpt delta mice is influenced by sex.
    Int J Cancer. 2019 Apr 11. doi: 10.1002/ijc.32332.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  24. WATSON H, Guevara M, Vilstrup H, Gines P, et al
    Improvement of hyponatremia in cirrhosis is associated with improved complex information processing.
    J Gastroenterol Hepatol. 2019 Apr 9. doi: 10.1111/jgh.14683.
    PubMed     Text format     Abstract available


    J Hepatol

  25. GERARD C, Di-Luoffo M, Gonay L, Caruso S, et al
    Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma.
    J Hepatol. 2019 Apr 3. pii: S0168-8278(19)30195.
    PubMed     Text format     Abstract available

  26. CABIBBO G, Celsa C, Calvaruso V, Petta S, et al
    Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
    J Hepatol. 2019 Apr 5. pii: S0168-8278(19)30221.
    PubMed     Text format     Abstract available

  27. WANDELER G, Mauron E, Atkinson A, Dufour JF, et al
    Incidence of Hepatocellular Carcinoma in HIV/HBV-coinfected Patients on Tenofovir therapy: Relevance for Screening Strategies.
    J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30226.
    PubMed     Text format     Abstract available

  28. OVEREEM AW, Klappe K, Parisi S, Kloters-Planchy P, et al
    Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity.
    J Hepatol. 2019 Apr 6. pii: S0168-8278(19)30225.
    PubMed     Text format     Abstract available


    J Pediatr

  29. FANNA M, Rougemont AL, Arni D, Toso C, et al
    Giant Intrahepatic Lipoblastoma in a Child.
    J Pediatr. 2019 Apr 4. pii: S0022-3476(19)30272.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  30. THOMAS T, Chandan JS, Bhala N
    Unmet needs in end-of-life care for chronic liver disease.
    Lancet Gastroenterol Hepatol. 2019;4:6-7.
    PubMed     Text format    

  31. SANDUZZI-ZAMPARELLI M, Forner A
    Systemic doxorubicin and hepatocellular carcinoma: the end of an era never risen up.
    Lancet Gastroenterol Hepatol. 2019 Apr 3. pii: S2468-1253(19)30091.
    PubMed     Text format    

  32. MERLE P, Blanc JF, Phelip JM, Pelletier G, et al
    Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2019 Apr 3. pii: S2468-1253(19)30040.
    PubMed     Text format     Abstract available


  33. Correction to Lancet Gastroenterol Hepatol 2019; 4: 135-84.
    Lancet Gastroenterol Hepatol. 2019;4:e4.
    PubMed     Text format    

  34. TSENG TC, Shih YF, Liu CJ
    A simple non-invasive test for ruling out cirrhosis in chronic hepatitis B.
    Lancet Gastroenterol Hepatol. 2019 Apr 8. pii: S2468-1253(19)30118.
    PubMed     Text format    

  35. SONNEVELD MJ, Brouwer WP, Chan HL, Piratvisuth T, et al
    Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study.
    Lancet Gastroenterol Hepatol. 2019 Apr 8. pii: S2468-1253(19)30087.
    PubMed     Text format     Abstract available


    Lancet Haematol

  36. KANDA Y
    Is pharmacokinetic guidance a must in busulfan regimens?
    Lancet Haematol. 2018;5:e498-e499.
    PubMed     Text format    


    Lancet Oncol

  37. KATZENSTEIN HM, Langham MR, Malogolowkin MH, Krailo MD, et al
    Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Lancet Oncol. 2019 Apr 8. pii: S1470-2045(18)30895.
    PubMed     Text format     Abstract available

  38. DAS M
    TACE plus external beam radiotherapy in liver cancer.
    Lancet Oncol. 2018;19:e231.
    PubMed     Text format    

  39. RANSCOMBE P
    Don't let the data cloud the image.
    Lancet Oncol. 2018;19:736.
    PubMed     Text format    

  40. HAEMMERICH D
    Non-invasive image-guided targeted drug delivery.
    Lancet Oncol. 2018;19:1000-1001.
    PubMed     Text format    

  41. CZAUDERNA P
    Is it worth completely resecting hepatoblastoma at diagnosis?
    Lancet Oncol. 2019 Apr 8. pii: S1470-2045(19)30096.
    PubMed     Text format    


    N Engl J Med

  42. VILLANUEVA A
    Hepatocellular Carcinoma.
    N Engl J Med. 2019;380:1450-1462.
    PubMed     Text format    


    PLoS One

  43. LIEN HC, Jeng YM, Jhuang YL, Yuan RH, et al
    Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.
    PLoS One. 2018;13:e0206261.
    PubMed     Text format     Abstract available

  44. BONKOVSKY HL, Barnhart HX, Foureau DM, Steuerwald N, et al
    Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
    PLoS One. 2018;13:e0206389.
    PubMed     Text format     Abstract available

  45. CHANG E, Kim DH, Yang H, Lee DH, et al
    CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.
    PLoS One. 2018;13:e0206152.
    PubMed     Text format     Abstract available

  46. XIONG Y, Zhang Q, Ye J, Pan S, et al
    Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    PLoS One. 2018;13:e0206853.
    PubMed     Text format     Abstract available

  47. ADAMS LC, Lubbe F, Bressem K, Wagner M, et al
    Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.
    PLoS One. 2018;13:e0206450.
    PubMed     Text format     Abstract available

  48. KIM EJ, Chung DH, Kim YJ, Kim YS, et al
    Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.
    PLoS One. 2018;13:e0206694.
    PubMed     Text format     Abstract available

  49. CHIANG HC, Chien YC, Lin PY, Lee HL, et al
    Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings.
    PLoS One. 2018;13:e0206438.
    PubMed     Text format     Abstract available

  50. VAN DER WAALS LM, Borel Rinkes IHM, Kranenburg O
    ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    PLoS One. 2018;13:e0205536.
    PubMed     Text format     Abstract available


    Semin Liver Dis

  51. WEINBERG EM, Palecki J, Reddy KR
    Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
    Semin Liver Dis. 2019 Apr 12. doi: 10.1055/s-0039-1679934.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: